tiprankstipranks
Trending News
More News >
Seach Medical Group Ltd. (IL:SEMG)
:SEMG
Israel Market
Advertisement

Seach Medical (SEMG) Ratios

Compare
0 Followers

Seach Medical Ratios

IL:SEMG's free cash flow for Q2 2025 was 0.31. For the 2025 fiscal year, IL:SEMG's free cash flow was decreased by and operating cash flow was 0.11. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.34 2.77 2.46 3.15 6.77
Quick Ratio
1.85 1.53 1.42 1.86 4.67
Cash Ratio
0.45 0.40 0.59 0.85 2.69
Solvency Ratio
0.38 -0.16 0.03 0.25 0.98
Operating Cash Flow Ratio
1.17 <0.01 0.47 -0.31 -0.61
Short-Term Operating Cash Flow Coverage
7.89 0.04 2.99 -0.75 0.00
Net Current Asset Value
51.65M 29.31M 29.91M 49.85M 50.57M
Leverage Ratios
Debt-to-Assets Ratio
0.13 0.18 0.17 0.11 0.02
Debt-to-Equity Ratio
0.21 0.30 0.31 0.16 0.02
Debt-to-Capital Ratio
0.17 0.23 0.24 0.14 0.02
Long-Term Debt-to-Capital Ratio
<0.01 <0.01 <0.01 0.00 0.00
Financial Leverage Ratio
1.57 1.69 1.88 1.49 1.17
Debt Service Coverage Ratio
2.15 -0.05 1.10 0.57 33.29
Interest Coverage Ratio
6.19 0.00 2.63 10.78 32.33
Debt to Market Cap
0.05 0.10 0.10 0.09 0.00
Interest Debt Per Share
0.63 0.68 0.83 0.43 0.06
Net Debt to EBITDA
0.37 9.75 0.56 -1.11 -3.86
Profitability Margins
Gross Profit Margin
31.29%24.88%28.54%34.16%46.04%
EBIT Margin
9.41%-1.57%3.00%6.55%12.74%
EBITDA Margin
10.56%0.86%6.92%10.97%16.74%
Operating Profit Margin
7.65%-4.56%3.00%6.55%12.74%
Pretax Profit Margin
8.22%-6.84%-3.03%9.25%36.14%
Net Profit Margin
8.19%-6.99%-2.54%7.94%32.52%
Continuous Operations Profit Margin
5.69%-7.90%-3.93%7.76%32.52%
Net Income Per EBT
99.72%102.26%83.87%85.83%89.98%
EBT Per EBIT
107.35%149.93%-100.89%141.38%283.68%
Return on Assets (ROA)
9.36%-8.03%-2.11%4.16%12.87%
Return on Equity (ROE)
15.16%-13.56%-3.96%6.22%15.10%
Return on Capital Employed (ROCE)
10.82%-6.52%3.22%4.31%5.62%
Return on Invested Capital (ROIC)
7.08%-6.99%3.94%3.26%5.03%
Return on Tangible Assets
11.08%-9.89%-2.61%4.88%12.87%
Earnings Yield
15.11%-17.16%-5.52%4.37%5.35%
Efficiency Ratios
Receivables Turnover
10.77 6.59 5.62 3.56 4.68
Payables Turnover
7.59 9.71 4.77 8.49 19.00
Inventory Turnover
2.74 3.54 2.52 1.31 0.99
Fixed Asset Turnover
7.44 5.37 4.08 4.42 2.68
Asset Turnover
1.14 1.15 0.83 0.52 0.40
Working Capital Turnover Ratio
2.61 3.03 2.44 1.21 0.84
Cash Conversion Cycle
118.85 120.81 133.14 338.40 425.92
Days of Sales Outstanding
33.88 55.42 64.96 102.59 77.97
Days of Inventory Outstanding
133.07 102.98 144.67 278.80 367.15
Days of Payables Outstanding
48.10 37.58 76.49 43.00 19.21
Operating Cycle
166.95 158.40 209.63 381.40 445.13
Cash Flow Ratios
Operating Cash Flow Per Share
0.98 <0.01 0.51 -0.24 -0.18
Free Cash Flow Per Share
0.94 -0.02 0.47 -0.30 -0.31
CapEx Per Share
0.03 0.03 0.04 0.06 0.14
Free Cash Flow to Operating Cash Flow
0.97 -2.96 0.93 1.23 1.78
Dividend Paid and CapEx Coverage Ratio
6.37 0.25 14.08 -4.29 -1.28
Capital Expenditure Coverage Ratio
28.64 0.25 14.08 -4.29 -1.28
Operating Cash Flow Coverage Ratio
1.73 <0.01 0.65 -0.58 -3.28
Operating Cash Flow to Sales Ratio
0.20 <0.01 0.13 -0.12 -0.16
Free Cash Flow Yield
35.41%-1.09%26.17%-8.19%-4.58%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
6.62 -5.83 -18.10 22.88 18.68
Price-to-Sales (P/S) Ratio
0.54 0.41 0.46 1.82 6.07
Price-to-Book (P/B) Ratio
0.97 0.79 0.72 1.42 2.82
Price-to-Free Cash Flow (P/FCF) Ratio
2.82 -91.96 3.82 -12.21 -21.85
Price-to-Operating Cash Flow Ratio
2.75 272.19 3.55 -15.06 -38.86
Price-to-Earnings Growth (PEG) Ratio
-0.76 -0.03 0.11 -0.40 -0.13
Price-to-Fair Value
0.97 0.79 0.72 1.42 2.82
Enterprise Value Multiple
5.46 57.11 7.21 15.45 32.43
Enterprise Value
95.14M 73.85M 66.91M 114.16M 199.74M
EV to EBITDA
5.46 57.11 7.21 15.45 32.43
EV to Sales
0.58 0.49 0.50 1.70 5.43
EV to Free Cash Flow
3.03 -110.89 4.14 -11.39 -19.52
EV to Operating Cash Flow
2.92 328.22 3.85 -14.04 -34.73
Tangible Book Value Per Share
2.43 1.89 2.07 2.27 2.43
Shareholders’ Equity Per Share
2.75 2.28 2.53 2.55 2.43
Tax and Other Ratios
Effective Tax Rate
0.31 -0.15 -0.30 0.16 0.10
Revenue Per Share
4.94 4.42 3.94 1.99 1.13
Net Income Per Share
0.41 -0.31 -0.10 0.16 0.37
Tax Burden
1.00 1.02 0.84 0.86 0.90
Interest Burden
0.87 4.35 -1.01 1.41 2.84
Research & Development to Revenue
<0.01 0.01 0.01 0.03 0.05
SG&A to Revenue
0.05 0.06 0.06 0.11 0.21
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 0.02 0.05
Income Quality
2.41 -0.02 -5.10 -1.52 -0.48
Currency in ILS
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis